These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 311279)

  • 1. The influence of pharmacological manipulation of serotonergic and dopaminergic mechanisms on plasma prolactin in ovariectomized, estrogen-treated rats.
    Lawson DM; Gala RR
    Endocrinology; 1978 Mar; 102(3):973-81. PubMed ID: 311279
    [No Abstract]   [Full Text] [Related]  

  • 2. Serotonergic stimulation of prolactin release in the young turkey (Meleagris gallopavo).
    Fehrer SC; Silsby JL; El Halawani ME
    Gen Comp Endocrinol; 1983 Dec; 52(3):400-8. PubMed ID: 6230284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The acute effects of 5HTP, fluoxetine and quipazine on insulin and glucagon release in the intact rat.
    Jacoby JH; Bryce GF
    Horm Metab Res; 1979 Feb; 11(2):90-4. PubMed ID: 312241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the role of the central serotoninergic system in the regulation of the secretion of thyrotropin and prolactin: thyrotropin-inhibiting and prolactin-releasing effects of 5-hydroxytryptamine and quipazine in the male rat.
    Krulich L; Vijayan E; Coppings RJ; Giachetti A; McCann SM; Mayfield MA
    Endocrinology; 1979 Jul; 105(1):276-83. PubMed ID: 446410
    [No Abstract]   [Full Text] [Related]  

  • 5. The interaction of dopaminergic and serotonergic drugs on plasma prolactin in ovariectomized, estrogen-treated rats.
    Lawson DM; Gala RR
    Endocrinology; 1976 Jan; 98(1):42-7. PubMed ID: 1248448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential ontogeny of opioid, dopaminergic and serotonergic regulation of prolactin secretion.
    Bero LA; Kuhn CM
    J Pharmacol Exp Ther; 1987 Mar; 240(3):825-30. PubMed ID: 3031276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opiate-serotonin synergism stimulating luteinizing hormone release in estrogen-progesterone-primed ovariectomized rats: mediation by serotonin2 receptors.
    Lenahan SE; Seibel HR; Johnson JH
    Endocrinology; 1987 Apr; 120(4):1498-502. PubMed ID: 3830057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of quipazine, a serotonin receptor agonist, on serum corticosterone concentration in rats.
    Fuller RW; Snoddy HD; Clemens JA
    Endocr Res Commun; 1978; 5(2):161-71. PubMed ID: 309816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quipazine exacerbation of a hyperkinetic syndrome: involvement of brain dopamine and serotonin.
    Langlais PJ; Gabay S
    J Neurosci Res; 1977; 3(2):135-41. PubMed ID: 563925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin-induced head shaking behavior in rats does not involve receptors located in the frontal cortex.
    Lucki I; Minugh-Purvis N
    Brain Res; 1987 Sep; 420(2):403-6. PubMed ID: 2960422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the mode of the prolactin release-inhibiting action of the serotonin receptor blockers metergoline, methysergide, and cyproheptadine.
    Krulich L; McCann SM; Mayfield MA
    Endocrinology; 1981 Apr; 108(4):1115-24. PubMed ID: 7472261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin and luteinizing hormone levels of prelaying, laying and postlaying turkey hens following central administration of serotonin and peripheral administration of quipazine maleate.
    Hargis BM; Burke WH
    Gen Comp Endocrinol; 1984 Jul; 55(1):12-9. PubMed ID: 6235145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further evidence that serotonin is a neurotransmitter involved in the control of prolactin secretion.
    Clemens JA; Sawyer BD; Cerimele B
    Endocrinology; 1977 Mar; 100(3):692-8. PubMed ID: 401022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of pharmacological manipulation of serotonin on serum growth hormone and luteinizing hormone levels in young turkeys (Meleagris gallopavo).
    Fehrer SC; Silsby JL; Burke WH; el Halawani ME
    Poult Sci; 1985 Jul; 64(7):1356-62. PubMed ID: 3161015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of quipazine and methysergide on play in juvenile rats.
    Normansell L; Panksepp J
    Pharmacol Biochem Behav; 1985 May; 22(5):885-7. PubMed ID: 2989950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of quipazine on blood pressure in pithed rats.
    Shin YK; Svinareff P; Schmitt-Jubeau H; Schmitt H
    Arch Int Pharmacodyn Ther; 1983 Jul; 264(1):73-81. PubMed ID: 6138006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the behavioral effects of para-chloroamphetamine, chlordimeform, quipazine, and intraventricular serotonin in the rat.
    Pfister WR; Noland V; Lowy MT; Nichols DE; Yim GK
    Commun Psychopharmacol; 1978; 2(4):287-95. PubMed ID: 729354
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of methysergide, a blocker of serotonin receptors, on plasma prolactin levels in lactating and ovariectomized rats.
    Gallo RV; Rabii J; Moberg GP
    Endocrinology; 1975 Nov; 97(5):1096-105. PubMed ID: 126860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combined effect of quipazine and haloperidol on plasma prolactin release.
    Feigenbaum J; Yanai J; Klawans HL; Chatterton R
    Int J Neurosci; 1983; 18(1-2):37-40. PubMed ID: 6840980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic activity of quipazine.
    Schechter MD; Concannon JT
    Pharmacol Biochem Behav; 1982 Sep; 17(3):393-7. PubMed ID: 7146043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.